Semaglutide: Your First 3 Months Week by Week
What does week 1 feel like compared to week 12? A realistic timeline of what to expect in your first three months on semaglutide, from a Houston patient perspective.
Reviewed for accuracy against current FDA guidance, peer-reviewed clinical trial data (STEP, SURMOUNT trials), and manufacturer prescribing information. See our editorial standards.
Most Houston patients on semaglutide notice appetite suppression within the first week, but meaningful weight loss — typically 5–10% of body weight — takes closer to 12 weeks to show up consistently. The first month is dominated by side effects: nausea, fatigue, and GI discomfort that peak around weeks two and three, then ease for most people. Dose escalation, which clinics in Sugar Land, The Woodlands, and across the Houston metro handle differently, plays a big role in how rough or smooth that early stretch feels. This article walks through the semaglutide timeline week by week so you know what's normal, what's worth calling your clinic about, and when to expect the scale to start moving.
1Weeks 1 to 4: The Starting Dose Phase
The standard starting dose of semaglutide is 0.25 mg weekly, which is a sub-therapeutic dose designed to let your body adjust before any meaningful weight loss dose is reached. During these first four weeks, some patients notice mild appetite reduction and some nausea, particularly after injection day. Do not be discouraged if you are not losing weight yet. The scale often does not move significantly at the 0.25 mg dose, and that is expected. Focus on establishing your injection routine, practicing smaller portions, and tracking your protein intake.
2Weeks 5 to 8: Dose Increase and First Real Results
At week 5, most protocols increase the dose to 0.5 mg weekly. This is often when patients notice the first significant change in appetite and the scale starts moving. Weight loss of 2 to 4 pounds per month is typical at this stage, though some patients see more. Nausea tends to be most prominent at each dose increase and then improves. If you had minimal nausea at 0.25 mg, expect some increase at 0.5 mg. Most patients find it manageable with the dietary adjustments described in nutrition guides. Your clinic will likely schedule a check-in around week 8.
3Weeks 9 to 12: Building Momentum
By month three, most patients are either continuing at 0.5 mg or have moved to 1 mg depending on response and tolerability. GI symptoms have usually improved significantly from the early weeks. Appetite suppression is more consistent and patients report that food cravings, particularly for ultra-processed or sugary foods, are noticeably reduced. Average weight loss by the 12-week mark is typically 4 to 8 percent of starting body weight when combining medication with dietary effort, though results vary widely. Patients who have incorporated regular protein intake and reduced processed food intake often see results toward the higher end of that range.
4The First Plateau: What It Means
Many patients hit their first weight loss plateau somewhere between weeks 8 and 16. The scale stalls for two to four weeks despite no change in behavior. This is a normal part of metabolic adaptation and does not mean the medication has stopped working. The body temporarily adjusts its energy expenditure in response to weight loss. Most Houston physicians recommend staying the course, reviewing protein and caloric intake for unintentional increases, and checking whether the current dose is still appropriate. A dose increase is sometimes appropriate at this stage.
5What 3 Months Does Not Tell You
Three months is a meaningful checkpoint but not the full picture. The largest weight losses on semaglutide typically occur between months 4 and 12, particularly after reaching the therapeutic dose range of 1 mg to 2.4 mg. Patients who show modest results at week 12 should not assume the medication is not working for them. One exception is if you are experiencing no appetite suppression and no weight loss at the higher doses after full titration. That warrants a conversation with your physician about whether semaglutide is the right option or whether switching to tirzepatide makes sense.
The first three months on semaglutide are an adjustment period as much as a weight loss period. The patients who get the most out of the medication are those who use that time to build habits that reinforce the appetite changes the drug creates. Find a Houston weight loss clinic that includes nutritional guidance alongside the prescription, and plan check-ins at weeks 4, 8, and 12 to review your progress and dose.
Sources & References
Clinical data referenced in this article is drawn from the FDA drug database, peer-reviewed publications (STEP trials, SURMOUNT trials), and manufacturer prescribing information for Wegovy, Ozempic, Zepbound, and Mounjaro. Pricing figures reflect publicly available estimates and may vary. Insurance coverage information is general guidance — confirm your specific benefits with your plan.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed physician before starting any weight loss medication or program.